Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Guo

Showing results (561-570 of 631) with videos related to

Pageof 64
Sort By:
Oral Oncology|June 11, 2019
Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinomaXue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
Plos One|September 11, 2009
The survey of H5N1 flu virus in wild birds in 14 Provinces of China from 2004 to 2007Zheng Kou, Yongdong Li, Zuohua Yin, et al.
Frontiers in Cellular and Infection Microbiology|May 23, 2024
Crosstalk between human immunodeficiency virus infection and salivary bacterial function in men who have sex with menYing Guo, Wenjing Wang, Yixi Yu, et al.
BMC Cancer|December 31, 2018
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysisYu-Jing Liang, Lin-Quan Tang, Xue-Song Sun, et al.
Blood|August 9, 2013
Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopeniaJi Ma, Yun-Na Ning, Miao Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2026
Long-Term Outcomes of Reduced-Dose Radiotherapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II TrialYu-Xi Xiao, Jin-Hao Yang, Xue-Song Sun, et al.
BMC Cancer|October 9, 2016
With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control studyLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
BMJ Oncology|August 5, 2025
Real-world experience on efficacy and safety of different adjuvant chemotherapy regimens in locoregionally advanced nasopharyngeal carcinomaJie Chen, Hui Cheng, Yi-Fu Li, et al.
European Journal of Radiology|September 20, 2025
Potential values of uEXPLORER total-body PET/CT in nasopharyngeal carcinoma: dynamic imaging and kinetic parametersYing-Ying Hu, Zhen-Chong Yang, Li-Ping Liang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2023
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinomaYu-Chen, Mei-Juan Luo, Rong-Ping Liu, et al.
Pageof 64

Showing results (561-570 of 631) with videos related to

Sort By:
Pageof 64
Oral Oncology|June 11, 2019
Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinomaXue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
Plos One|September 11, 2009
The survey of H5N1 flu virus in wild birds in 14 Provinces of China from 2004 to 2007Zheng Kou, Yongdong Li, Zuohua Yin, et al.
Frontiers in Cellular and Infection Microbiology|May 23, 2024
Crosstalk between human immunodeficiency virus infection and salivary bacterial function in men who have sex with menYing Guo, Wenjing Wang, Yixi Yu, et al.
BMC Cancer|December 31, 2018
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysisYu-Jing Liang, Lin-Quan Tang, Xue-Song Sun, et al.
Blood|August 9, 2013
Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopeniaJi Ma, Yun-Na Ning, Miao Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2026
Long-Term Outcomes of Reduced-Dose Radiotherapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II TrialYu-Xi Xiao, Jin-Hao Yang, Xue-Song Sun, et al.
BMC Cancer|October 9, 2016
With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control studyLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
BMJ Oncology|August 5, 2025
Real-world experience on efficacy and safety of different adjuvant chemotherapy regimens in locoregionally advanced nasopharyngeal carcinomaJie Chen, Hui Cheng, Yi-Fu Li, et al.
European Journal of Radiology|September 20, 2025
Potential values of uEXPLORER total-body PET/CT in nasopharyngeal carcinoma: dynamic imaging and kinetic parametersYing-Ying Hu, Zhen-Chong Yang, Li-Ping Liang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2023
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinomaYu-Chen, Mei-Juan Luo, Rong-Ping Liu, et al.
Pageof 64